Cite

    Laura May Davis et al.. “Timing of peptide receptor radiotargeted therapy in relation to cardiac valve surgery for carcinoid heart disease in patients with neuroendocrine metastases and cardiac syndrome. A single-centre study from a centre of excellence.” Nuclear medicine communications, vol. 41, no. 6, 2020, p. . http://access.bl.uk/ark:/81055/vdc_100106106356.0x000014